FDA PMA FDA Class 3 Approved 🇺🇸 United States

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

PMA: P010031 · Supplement: S858 · Decision Sep 27, 2024
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Trade Name
Amolia MRI CRT-D, Amolia MRI Quad CRT-D, Brava CRT-D, Brava Quad CRT-D, Claria MRI CRT-D, Claria MRI Quad CRT-D, Compia
PMA Number
P010031
Supplement Number
S858
Device Class
FDA Class 3
Product Code
NIK
Generic Name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 27, 2024
Date Received
May 6, 2024
Supplement Type
135 Review Track For 30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

to use an updated ceramic in the surface acoustic wave (SAW) filter used in the Tel M module

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)